BeOne Medicines Ltd. (ONC) operating KPIs
ONCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as BEIGF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/302313% above fair value
$370.33−1.23 (-0.33%)
Close on Oct 30, 2026Market cap $42.11BP/E 66.2Yield –
BeOne Medicines pRC Subsidiaries Restricted Net Assets ($M) ($M)
Form 10-K Restricted Net Assets Note (XBRL)
Latest, FY2025
2,012
Period ended Dec 31, 2025
Change on a year earlier
+17.7%
1,710 in FY2024
History
11 years
Since FY2015
Sources
10
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | PRC Subsidiaries Restricted Net Assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2,012 | +17.7% | Form 10-K (filed 2026-02-26) ↗ |
| FY2024 | Dec 31, 2024 | 1,710 | -19.1% | Form 10-K (filed 2026-02-26) ↗ |
| FY2023 | Dec 31, 2023 | 2,114 | -40.4% | Form 10-K (filed 2025-02-27) ↗ |
| FY2022 | Dec 31, 2022 | 3,549 | +366.7% | Form 10-K (filed 2024-02-26) ↗ |
| FY2021 | Dec 31, 2021 | 761 | +534.8% | Form 10-K (filed 2023-02-27) ↗ |
| FY2020 | Dec 31, 2020 | 120 | +9.3% | Form 10-K (filed 2022-02-28) ↗ |
| FY2019 | Dec 31, 2019 | 110 | +17.5% | Form 10-K (filed 2021-02-25) ↗ |
| FY2018 | Dec 31, 2018 | 93.3 | +212.0% | Form 10-K (filed 2020-03-02) ↗ |
| FY2017 | Dec 31, 2017 | 29.9 | +199.0% | Form 10-K (filed 2019-02-28) ↗ |
| FY2016 | Dec 31, 2016 | 10 | +194.1% | Form 10-K (filed 2018-02-28) ↗ |
| FY2015 | Dec 31, 2015 | 3.40 | – | Form 10-K (filed 2017-03-22) ↗ |
Cite this data
StockData. (2026). BeOne Medicines PRC Subsidiaries Restricted Net Assets ($M) ($M), annual FY2015–FY2025 [Data set]. Compiled from BeOne Medicines SEC filings and investor materials. https://stockdatahq.com/stocks/onc/kpis/restricted_cn
See every metric in the BeOne Medicines KPI table. Data updated Oct 29, 2026.